The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining
Open accessAbstract
Methods to introduce targeted double-strand breaks (DSBs) into DNA enable precise genome editing by increasing the rate at which externally supplied DNA fragments are incorporated into the genome through homologous recombination. The efficiency of these methods is limited by nonhomologous end joining (NHEJ), an alternative DNA repair pathway that competes with homology-directed repair (HDR). To promote HDR at the expense of NHEJ, we targeted DNA ligase IV, a key enzyme in the NHEJ pathway, using the inhibitor Scr7. Scr7 treatment increased the efficiency of HDR-mediated genome editing, using Cas9 in mammalian cell lines and in mice for all four genes examined, up to 19-fold. This approach should be applicable to other customizable endonucleases, such as zinc finger nucleases and transcription activator-like effector nucleases, and to nonmammalian cells with sufficiently conserved mechanisms of NHEJ and HDR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Even in the presence of donor template DNA, NHEJ is the more frequent repair mechanism observed from CRISPR/Cas9 editing (Maruyama et al., 2015).”
From Delivering CRISPR: a review of the challenges and approaches (2018) · cites this paper as Maruyama et al., 2015
The cited source says what the claim attributes to it.
In the citing paper
“or inhibiting the NHEJ pathway [113] have shown to be useful as means of increasing the efficiency of HDR after Cas9 cleavage.”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [113]
In the citing paper
“Although inhibiting the NHEJ pathway with gene silencing or chemical inhibitors can partially increase the efficiency of HDR pathway, the gene repair efficacy still needs to be further improved for disease therapy [82, 85].”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [85]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
CRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
Genetic screens in human cells using the CRISPR-Cas9 system
Wang, T., Wei, J. J., Sabatini, D. M., & Lander, E. S. (2014) · Science · doi:10.1126/science.1246981 · Cited by 2,856
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429
RNA-guided genetic silencing systems in bacteria and archaea
Wiedenheft, B., Sternberg, S. H., & Doudna, J. A. (2012) · Nature · doi:10.1038/nature10886 · Cited by 1,851
Yang, H., Wang, H., Shivalila, C. S., Cheng, A. W., Shi, L., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.08.022 · Cited by 1,596
Double-strand break repair: 53BP1 comes into focus
Panier, S., & Boulton, S. J. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3719 · Cited by 1,168
Kamentsky, L. D., Jones, T. R., Fraser, A. N., Bray, M., Logan, D. J., Madden, K. L., Ljosa, V., Rueden, C., Eliceiri, K. W., & Carpenter, A. E. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr095 · Cited by 1,002
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 1,000
Trionfini, P., Ciampi, O., Todeschini, M., Ascanelli, C., Longaretti, L., Perico, L., Remuzzi, G., Benigni, A., & Tomasoni, S. (2019) · The CRISPR Journal · doi:10.1089/crispr.2018.0048 · Cited by 7
Water-soluble SCR7 Can Abrogate DNA End Joining and Induce Cancer Cell Death
Raghavan, S. C., Ray, U., Jose, A. E., Suresh, R., Kaloor, U., Swarup, H. A., Nambiar, M., & Raghavan, S. C. (2020) · Clinical Oncology and Research · doi:10.31487/j.cor.2020.07.09 · Cited by 7
A polyclonal allelic expression assay for detecting regulatory effects of transcript variants
Brandt, M. K., Gokden, A., Ziosi, M., & Lappalainen, T. (2020) · Genome Medicine · doi:10.1186/s13073-020-00777-8 · Cited by 7
Interrogation of Functional miRNA–Target Interactions by CRISPR/Cas9 Genome Engineering
Michaels, Y. S., Wu, Q., & Fulga, T. A. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6866-4_7 · Cited by 7
Genome editing technologies and their potential to treat neurologic disease
Madigan, N. N., Staff, N. P., Windebank, A. J., & Benarroch, E. E. (2017) · Neurology · doi:10.1212/wnl.0000000000004558 · Cited by 7
Ye, L., Wang, J., Teque, F., Xie, F., Tan, Y., Kan, Y. W., & Levy, J. A. (2020) · AIDS · doi:10.1097/qad.0000000000002535 · Cited by 7
Nidhi, F., & Tomatsu, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146616 · Cited by 6
Dendritic cell redundancy enables priming of anti-tumor CD4+ T cells in pancreatic cancer
Kureshi, C. T. S., Walsh, M. J., Kureshi, R., Cardot‐Ruffino, V., Agardy, D. A., Ali, L. R., Dougan, J. M., Li, Q., Shen, J., Zuo, C., et al. (2026) · Cancer Cell · doi:10.1016/j.ccell.2026.04.005 · Cited by 8
Self-citationPrecise genomic integration of large DNA fragments by donor-directed annealing using prime editing
Jung, H., Jeong, B., Kim, Y.-W., Jung, C., Lee, S., Uhm, H., Kim, H., Oh, Y. E., Park, Y. H., Lee, Y., et al. (2026) · Nature Biotechnology · doi:10.1038/s41587-026-03301-2 · Cited by 6
MDM2 antagonists promote CRISPR/Cas9-mediated precise genome editing in sheep primary cells
Li, Y., Lian, D., Wang, J., Zhao, Y., Li, Y., Liu, G., Wu, S., Deng, S., Du, X., & Lian, Z. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.12.020 · Cited by 6
Large-Scale CRISPR Screen of LDLR Pathogenic Variants
Li, M., Ma, L., Chen, Y., Li, J., Wang, Y., You, W., Yuan, H., Tang, X., Ouyang, H., & Pang, D. (2023) · Research · doi:10.34133/research.0203 · Cited by 6
Liu, J., Li, W., Jin, X., Lin, F., Han, J., & Zhang, Y. (2023) · Communications Biology · doi:10.1038/s42003-023-05686-1 · Cited by 6
Li, C., Liu, X., Li, Y., Peng, Q., Miao, J., & Liu, X. (2025) · Molecular Plant Pathology · doi:10.1111/mpp.70114 · Cited by 6
Lan, T., Chen, L., Wang, Y., & Jiao, Y. (2025) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00326-1 · Cited by 6
sgRNA-shRNA Structure Mediated SNP Site Editing on Porcine IGF2 Gene by CRISPR/StCas9
Sun, Y., Yan, N., Mu, L., Sun, B., Deng, J., Fang, Y., Shao, S., Yan, Q., Han, F., Zhang, Z., et al. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00347 · Cited by 6
Current Status of Production of Transgenic Livestock by Genome Editing Technology
Park, D. S., Kim, S., Koo, D., & Kang, M. (2019) · Journal of Animal Reproduciton and Biotechnology · doi:10.12750/jarb.34.3.148 · Cited by 6
He, X., Chen, W., Liu, Z., Yu, G., Chen, Y., Cai, Y., Sun, L., Xu, W., Zhong, L., Gao, C., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa195 · Cited by 6
Shen, L., Garay, J. P., Tubbs, C. A., & Franco, H. L. (2021) · FEBS Open Bio · doi:10.1002/2211-5463.13139 · Cited by 7
Monteiro, C. J., Heery, D. M., & Whitchurch, J. B. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-33325-5_2 · Cited by 6
Effects of RAD51-stimulatory compound 1 (RS-1) and its vehicle, DMSO, on pig embryo culture
Lucas, C. G., Redel, B. K., Chen, P. R., Spate, L. D., Prather, R. S., & Wells, K. D. (2021) · Reproductive Toxicology · doi:10.1016/j.reprotox.2021.08.002 · Cited by 6
Molecular approaches improving our understanding of Brettanomyces physiology
Varela, C., & Borneman, A. R. (2022) · FEMS Yeast Research · doi:10.1093/femsyr/foac028 · Cited by 6
Obermeier, M., Vadolas, J., Verhulst, S., Goossens, E., & Baert, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.891173 · Cited by 6
Meng, Q., Stoyko, D., Andrews, C. M., Κωνσταντινίδου, Π., Genzor, P., Timothy, O., Elchert, A. R., Benner, L., Sobti, S., Katz, E. Y., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac448 · Cited by 8
Editorial: Precise Genome Editing Techniques and Applications
Xu, K., Segal, D. J., & Zhang, Z. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00412 · Cited by 6
Farley, K. O., Forbes, C. A., Shaw, N. C., Kuzminski, E., Ward, M., Baynam, G., Lassmann, T., & Fear, V. S. (2024) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2023.100257 · Cited by 5
Prime editing-mediated microhomology enables efficient replacement of large DNA
Xie, Y., Li, P., He, Z., Huang, H., Wu, D., Ma, Z., Feng, S., Ran, J., Hou, K., Gao, F., et al. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag626 · Cited by 5
Zhao, Y.-J., Li, X., Liu, C., Jiang, C., Guo, X., Xu, Q., Yin, Z. X., Liu, Z. H., & Mu, Y. (2024) · Animals · doi:10.3390/ani14050719 · Cited by 5
Blastocyst complementation generates exogenous donor‐derived liver in ahepatic pigs
Simpson, S. G., Park, K., Yeddula, S. G. R., Waters, J., Scimeca, E., Poonooru, R. R., Etches, R., & Telugu, B. P. V. L. (2024) · The FASEB Journal · doi:10.1096/fj.202401244r · Cited by 5
Pan, H., Yu, W., & Zhang, M. (2019) · Bioscience Reports · doi:10.1042/bsr20191914 · Cited by 5
The applications of CRISPR/Cas-mediated genome editing in genetic hearing loss
Wu, J., Tao, Y., Deng, D., Meng, Z., & Zhao, Y. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01021-7 · Cited by 5
Discover Toxicology: An Early Safety Assessment Approach
Baker, T. K., Engle, S. K., Halstead, B. W., Paisley, B. M., Searfoss, G. H., & Willy, J. A. (2017) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-319-50042-3_5 · Cited by 5
CRISPR/Cas9-Mediated In Vitro Mutagenesis in GC-Like B Cells
Chu, V. T., Graf, R., & Rajewsky, K. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7095-7_12 · Cited by 5
Nguyen, T. T. T., Tamai, M., Harama, D., Kagami, K., Kasai, S., Watanabe, A., Akahane, K., Goi, K., & Inukai, T. (2022) · International Journal of Hematology · doi:10.1007/s12185-022-03369-x · Cited by 5
A Clathrin light chain A reporter mouse for in vivo imaging of endocytosis
Grimm, E., van der Hoeven, F., Sardella, D., Willig, K. I., Engel, U., Veits, N., Engel, R. R., Cavalcanti‐Adam, E. A., Bestvater, F., Bordoni, L., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273660 · Cited by 5
Applications of genome editing in farm animals
Kumar, D., & Kues, W. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816352-8.00005-9 · Cited by 5
RECAS9: Recombining wild species introgression via mitotic gene editing in barleyPreprint
Lazar, S., Prusty, M. R., Bishara, K., Sherman, A., & Fridman, E. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.07.897280 · Cited by 5
Genome Editing Tool CRISPR-Cas: Legal and Ethical Considerations for Life Science
Pandey, N., Arora, A., & Kumar, A. (2024) · Springer eBooks · doi:10.1007/978-981-99-8529-6_30 · Cited by 4
Deng, Y., Ding, X., Wu, Q., Cai, Y., Jin, J., Xu, Q., Zhu, J., & Chen, Y. (2024) · Biochemical Engineering Journal · doi:10.1016/j.bej.2024.109334 · Cited by 4
Harnessing the CRISPR/Cas9 in filamentous fungi for the production of secondary metabolites
Karim, M. D., Abuhena, M., Rahman, L., & Al-Rashid, J. (2025) · Systems Microbiology and Biomanufacturing · doi:10.1007/s43393-025-00346-3 · Cited by 4
Ferronato, G. D. A., da Silveira, J. C., & Ferraz, M. D. A. M. M. (2025) · Biology of Reproduction · doi:10.1093/biolre/ioaf195 · Cited by 4
Kim, H., Hyo-Gu, K., Oh, Y., Lee, W.-J., Lee, Y., Kim, E.-K., Nam, K.-H., Lee, D., Lee, S. H., & Sim, B. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf1444 · Cited by 4
Lu, M., & Billerbeck, S. (2024) · Microbial Biotechnology · doi:10.1111/1751-7915.14398 · Cited by 4
How to Shift the Equilibrium of DNA Break Repair in Favor of Homologous Recombination
Averina, O. A., Kuznetsova, S. A., Permyakov, O. A., & Владимирович, С. П. (2024) · Molecular Biology · doi:10.1134/s0026893324700201 · Cited by 4
Boosting CRISPR-Cas9 efficiency through enhanced homologous recombination
Ys, K., Yoon, S., & Kim, K. P. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102329 · Cited by 4
Getachew, H., Chinchilla, B., & Fernández‐Godino, R. (2021) · Methods in molecular biology · doi:10.1007/7651_2021_409 · Cited by 4
CRISPR-mediated Labeling of Cells in Chick Embryos Based on Selectively Expressed Genes
Yamagata, M., & Sanes, J. R. (2021) · BIO-PROTOCOL · doi:10.21769/bioprotoc.4105 · Cited by 4
CRISPR-Cas Gene Perturbation and Editing in Human Induced Pluripotent Stem Cells
van Essen, M. J., Riepsaame, J., & Jacob, J. (2021) · The CRISPR Journal · doi:10.1089/crispr.2021.0063 · Cited by 4
Gutierrez, K., Glanzner, W. G., de Macedo, M. P., Rissi, V. B., Dicks, N., Bohrer, R. C., Baldassarre, H., Agellon, L. B., & Bordignon, V. (2022) · Life · doi:10.3390/life12020171 · Cited by 4
Xing, D., Li, S., Shang, M., Wang, W., Zhang, Q., Wang, J., Hasin, T., Hettiarachchi, D. U., Alston, V. N., Bern, L., et al. (2022) · ACS Synthetic Biology · doi:10.1021/acssynbio.2c00252 · Cited by 4
Xu, X., Zhang, X., Peng, X., Liu, C., Li, W., & Liu, M. (2022) · Theriogenology · doi:10.1016/j.theriogenology.2022.11.044 · Cited by 4
Bridging Gaps in HDR Improvement: The Role of MAD2L2, SCAI, and SCR7
Anuchina, A. A., Zaynitdinova, M. I., Demchenko, A. G., Evtushenko, N. A., Лавров, А. В., & Smirnikhina, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076704 · Cited by 4
Miyamoto, T., Akutsu, S. N., & Matsuura, S. (2017) · Journal of Human Genetics · doi:10.1038/s10038-017-0349-z · Cited by 4
A Bioluminescence Resonance Energy Transfer–Based Reporter System: Characterization and Applications
Wimmer, T., Bonthu, D., Moeschl, V., Klekamp, P., Thiel, C., Lytvynchuk, L. M., Ellinwood, N. M., & Stieger, K. (2021) · The CRISPR Journal · doi:10.1089/crispr.2021.0023 · Cited by 4
Genome Editing with Targetable Nucleases
Pelletier, S. W. (2016) · Springer eBooks · doi:10.1007/978-3-319-34148-4_1 · Cited by 4
Boland, J. L., & Nedelcu, E. G. (2020) · The Permanente Journal · doi:10.7812/tpp/20.040 · Cited by 4
Tennant, P. A., Foster, R. G., Dodd, D. O., Sou, I. F., McPhie, F., Younger, N. T., Murphy, L. C., Pearson, M. W., Vernay, B., Keighren, M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.14.200170 · Cited by 4
CRISPR/Cas in dermatology: A scoping review of candidate diseases for clinical applications
Hwang, J. C., Brown, R., Ha, E. K., & Tung, J. K. (2025) · JAAD reviews. · doi:10.1016/j.jdrv.2025.05.003 · Cited by 3
Jin, X., Wu, X., Song, J., Luo, M., Ye, Q., Ren, C., Li, S., Li, M., Hu, M., An, Y., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.12.012 · Cited by 3
Viral genome editing methods and applications in the CRISPR era
Shin, K., & Kim, E. T. (2026) · Journal of Virology · doi:10.1128/jvi.02048-25 · Cited by 3
Leveraging CRISPR/Cas9 in notable bacteria for the production of industrially valuable compounds
Karim, M. D., Abuhena, M., Rahman, L., & Al-Rashid, J. (2025) · Systems Microbiology and Biomanufacturing · doi:10.1007/s43393-024-00326-z · Cited by 4
Gene editing using CRISPR-Cas9 technology: potential implications in assisted reproduction
Şahin, G. N., & Seli, E. U. (2025) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000001022 · Cited by 3
Natsagdorj, M., Hara, H., Uosaki, H., Nakahara, F., Inoue, M., & Hanazono, Y. (2026) · Communications Biology · doi:10.1038/s42003-026-09604-z · Cited by 4
CRISPR/Cas9 technology for targeted genome editing
Lomov, N. A., Borunova, V. V., & Rubtsov, M. A. (2015) · Biopolymers and Cell · doi:10.7124/bc.0008e7 · Cited by 3
Application of Genome Editing Technology to MicroRNA Research in Mammalians
Yu, L., Batara, J., & Lü, B. (2016) · InTech eBooks · doi:10.5772/64330 · Cited by 3
Current Status of Genome Editing in Cardiovascular Medicine
Termglinchan, V., Karakikes, I., Seeger, T., & Wu, J. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-34148-4_7 · Cited by 3
Molecular Switch Engineering for Precise Genome Editing
Matsumoto, D., & Nomura, W. (2021) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.1c00088 · Cited by 3
Selvaraj, D., Dawar, R., Kumar, S. P., & Devi, A. (2021) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2021-0062 · Cited by 3
Versatile generation of precise gene edits in bovines using SEGCPN
Wang, M., Ding, F., Wang, H., Li, L., Dai, Y., Sun, Z., & Li, N. (2023) · BMC Biology · doi:10.1186/s12915-023-01677-0 · Cited by 3
CRISPR Ribonucleoprotein-Mediated Precise Editing of Multiple Genes in Porcine Fibroblasts
Guo, X., Liu, C., Zhao, Y.-J., Jiang, C., Jin, J., Liu, Z. H., & Mu, Y. (2024) · Animals · doi:10.3390/ani14040650 · Cited by 3
Jang, J., Kim, M. J., Chang, S.-C., Han, J.-H., Bae, S., Jeon, H., Jo, D., & Nam, H. J. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e42971 · Cited by 3
Diploidy confers genomic instability in Schizosaccharomyces pombe
Park, J. M., Pinski, D. F., & Forsburg, S. L. (2025) · Genetics · doi:10.1093/genetics/iyaf078 · Cited by 3
Wilbie, D., Eising, S., Amo-Addae, V., Walther, J., Bosman, E., Lei, Z., de Jong, O. G., Molenaar, J. J., & Mastrobattista, E. (2025) · PLoS ONE · doi:10.1371/journal.pone.0332617 · Cited by 3
Tadjuidje, E., & Cha, S. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8784-9_8 · Cited by 3
Challenges to Gene Editing Approaches in the Retina
Bonillo, M., Pfromm, J. K., & Fischer, M. D. (2022) · Klinische Monatsblätter für Augenheilkunde · doi:10.1055/a-1757-9810 · Cited by 4
Tapping into the Unsung Potential of CRISPR/CAS Technology in Agriculture
Rehman, R. S., Ali, M., Zafar, S. A., Ahmad, M., Pasha, A. N., Bashir, H., Rashid, F., & Hussain, M. (2022) · Asian Journal of Biochemistry Genetics and Molecular Biology · doi:10.9734/ajbgmb/2022/v10i430249 · Cited by 3
CRISPR‐Cas9 Genome Editing and Rapid Selection of Cell Pools
Stoyko, D., Timothy, O., Hernandez, A., Κωνσταντινίδου, Π., Meng, Q., & Haase, A. D. (2022) · Current Protocols · doi:10.1002/cpz1.624 · Cited by 3
Lee, K., & Lee, C. (2023) · Scientific Reports · doi:10.1038/s41598-023-35203-7 · Cited by 3
Exonuclease editor promotes precision of gene editing in mammalian cells
Shi, H., Li, L., Mu, S., Gou, S., Liu, X., Chen, F., Chen, M., Jin, Q., Lai, L., & Wang, K. (2024) · BMC Biology · doi:10.1186/s12915-024-01918-w · Cited by 3
[Research advances on gene therapy for hemophilia A].
Li, X., Zhang, J., Zhang, L., Cheng, T., & Zhang, X. (2015) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2015.07.022 · Cited by 3
Endonuclease mediated genome editing in drug discovery and development: promises and challenges
Prabhu, V., & Xu, H. (2016) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2016.09.007 · Cited by 3
Mutagenesis and Transgenesis in Zebrafish
Poulain, F. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-33774-6_1 · Cited by 3
Generation of conditional Acvrl1 knockout mice by CRISPR/Cas9-mediated gene targeting
Xu, M., Xu, H., Chen, J., Chen, C., Xu, F., & Qin, Z. (2017) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2017.11.003 · Cited by 3
CRISPR/Cas9-Facilitated Chromosome Engineering to Model Human Chromosomal Alterations
Xing, Z., Li, Y., Pao, A., Kaas, G. A., & Yu, Y. (2018) · InTech eBooks · doi:10.5772/intechopen.70897 · Cited by 3
Characterization of Double-Strand Break Repair Protein Ku80 Location Within the Murine Retina
Müller, B., Serafin, F., Laucke, L. L., Rheinhard, W., Wimmer, T., & Stieger, K. (2022) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.63.6.22 · Cited by 3
Recent Progress in Genome Editing Approaches for Inherited Cardiovascular Diseases
Kaur, B., Perea‐Gil, I., & Karakikes, I. (2018) · Current Cardiology Reports · doi:10.1007/s11886-018-0998-3 · Cited by 3
New transgenic models of Parkinson's disease using genome editing technology
Cota-Coronado, J. A., Sandoval-Ávila, S., Gaytan-Dávila, Y. P., Díaz, N. F., Vega-Ruiz, B., Padilla‐Camberos, E., & Díaz-Martínez, N. E. (2019) · Neurología (English Edition) · doi:10.1016/j.nrleng.2017.08.006 · Cited by 4
A genetically encoded inhibitor of 53BP1 to stimulate homology-based gene editingPreprint
Canny, M. D., Wan, L. C. K., Fradet‐Turcotte, A., Orthwein, A., Moatti, N., Juang, Y.-C. A., Zhang, W., Noordermeer, S. M., Wilson, M. D., Vorobyov, A., et al. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/060954 · Cited by 3
Henze, S. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6012 · Cited by 3
Local recruitment of DNA repair proteins enhances CRISPR-ssODN-HDR editingPreprint
Jillette, N., Zhu, J. J., & Cheng, A. W. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.13.488255 · Cited by 3
Endogenous tagging using split mNeonGreen in human iPSCs for live imaging studies
Husser, M. C., Pham, N. P., Law, C., Araujo, F. R., Martin, V. J., & Piekny, A. (2024) · eLife · doi:10.7554/elife.92819 · Cited by 2
Generation of albino C57BL/6J mice by CRISPR embryo editing of the mouse tyrosinase locus
Diril, M. K., Esmen, K., Sehitogullari, T., & Öztürk, G. (2025) · Journal of Genetics · doi:10.1007/s12041-025-01493-1 · Cited by 2
Bousbaine, D., Obeng, E. M., Li, Z., Fang, T., Cheloha, R. W., Ploegh, H. L., & McCaul, N. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf062 · Cited by 2
Self-citationOjeda-Pérez, I., Bustos, A., Selvaraj, S., Fañanas-Baquero, S., Alberquilla, O., Serrano, L.-J., Bonafont, J., García-Torralba, A., Torres-Ruiz, R., Rodríguez, S., et al. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101615 · Cited by 3
Basic enables selection-free efficient knockin of large DNA in primary human T cells
Wang, K., Li, X., Li, J., Yu, Z., Li, P., Xie, Y., Liu, J., Huang, H., Zhang, S., Zhang, M., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2025.12.064 · Cited by 2
CRISPR-Cas at a crossroads: from microbial immunity to precision biotechnology
Eliwa, A. I. A., & Eldahshan, M. M. (2026) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2026.2658465 · Cited by 2
Cho, E., Lee, J., Kim, J., Choi, J., Kang, M., & Song, J. (2026) · Journal of Biological Engineering · doi:10.1186/s13036-026-00673-6 · Cited by 2
Li, Q., Cao, J., Deng, S., & Yu, K. (2026) · Xenotransplantation · doi:10.1111/xen.70128 · Cited by 2
Makhijani, S., Alasiri, G. A., Quadri, M. S. A., & Ingle, R. G. (2026) · Discover Nano · doi:10.1186/s11671-026-04653-z · Cited by 4
Technological advances in integrating multi-kilobase DNA sequences into genomes
Gurumurthy, C. B., & Pérez‐Piñera, P. (2018) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2018.08.004 · Cited by 2
Engineering Ligand and Receptor Pairs with LIPSTIC to Track Cell‐Cell Interactions
Alberti, D., Guarniero, M., Macioła, A. K., Dotta, E., & Pasqual, G. (2021) · Current Protocols · doi:10.1002/cpz1.311 · Cited by 2
Metadata
- Authors
- Maruyama, T., Dougan, S. K., Truttmann, M. C., Bilate, A. M., Ingram, J. R., & Ploegh, H. L.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Corresponding author
- Ploegh, Hidde L
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2015-03-23
- Volume
- 33
- Issue
- 5
- Pages
- 538-542
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC4618510
- OpenAlex
- W2008147758
- Cited by
- 1,137
- References
- 32
- Citations by year
- 2026: 39 · 2025: 58 · 2024: 62 · 2023: 67 · 2022: 108 · 2021: 101 · 2020: 117 · 2019: 122 · 2018: 125 · 2017: 139 · 2016: 143 · 2015: 55
- FWCI
- 66.47
- Type
- journal article
- Language
- en
- Update notices
- erratum (2016-02-05)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- PMC
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI087879)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- CRISPR/Cas9, genome editing efficiency, non-homologous end joining, homology-directed repair, DNA ligase IV, DNA double-strand break repair, zinc finger nucleases, TALEN
- MeSH terms
- DNA Ligase ATP, Animals, Cell Line, DNA Repair, Genetic Engineering, DNA Ligases, Pyrimidines, Schiff Bases, Zinc Fingers, Genome, Mice, DNA Breaks, Double-Stranded, Homologous Recombination, DNA End-Joining Repair, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review